Security
Exascale Labs Holdings Inc. Warrant · XLABW
XLABWNASDAQWarrantCurrentCIK 2109869Updated Oct 7, 2026
Name history
D. Boral ARC Merger Corp · through Jul 7, 2026
XLABW price & chart
Loading TradingView…
NASDAQ:XLABW on TradingView ↗About the company
Exascale is a next-generation AI infrastructure provider operating a software-defined GPU compute platform and related AI infrastructure solutions. Its business includes, GPU-as-a-service, GPU cluster management and optimization, and infrastructure solutions spanning modular data centers, HVDC power, high-density cooling, and data center interconnectivity. Exascale’s platform supports large-scale AI workloads, including training, fine-tuning, high-concurrency inference, and API-based token generation. For more information, visit www.exascalelabs.ai.
In the news
No coverage from other publishers is available.
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Results of Operations and Financial Condition
Items 2.02, 9.01
Completion of Acquisition or Disposition of Assets
Items 2.01, 9.01
10-K filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Show 3 more recent filings
Entry into a Material Definitive Agreement · Termination of a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Material Modification to Rights of Security Holders · Changes in Registrant's Certifying Accountant · Changes in Control of Registrant · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Change in Shell Company Status · Regulation FD Disclosure
Items 1.01, 1.02, 2.01, 3.01, 3.03, 4.01, 5.01, 5.02, 5.03, 5.06, 7.01, 9.01
CERT filing
8-A12B filing
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 |
|---|---|
| ASSETS | |
| AssetsUSD | 6,726,725Source |
| Property, Plant and Equipment, NetUSD | 12,840Source |
| Current assets: | |
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,693,586Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 1,145,232Source |
| Assets, CurrentUSD | 6,523,885Source |
| LIABILITIES AND EQUITY | |
| LiabilitiesUSD | 31,885,500Source |
| Stockholders’ equity: | |
| Additional Paid in CapitalUSD | 220,636Source |
| Retained Earnings (Accumulated Deficit)USD | -25,379,426Source |
| Stockholders' Equity Attributable to ParentUSD | -25,158,775Source |
| Liabilities and EquityUSD | 6,726,725Source |
| Current liabilities: | |
| Liabilities, CurrentUSD | 31,885,500Source |
| Accounts Payable, CurrentUSD | 916,422Source |
| Additional Financial Items | |
| Accounts Receivable, after Allowance for Credit LossUSD | 1,107,210Source |
cash flow · annual statements
| Line item | FY 2026 |
|---|---|
| Cash flows from operating activities: | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -12,162,391Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 0Source |
| Changes in operating assets and liabilities: | |
| Increase (Decrease) in Accounts ReceivableUSD | 992,696Source |
| Increase (Decrease) in Accounts PayableUSD | 826,407Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -2,754,624Source |
| Cash flows from investing activities: | |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 1,406,521Source |
| Cash flows from financing activities: | |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -190,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,693,586Source |
| Additional Financial Items | |
| DepreciationUSD | 6,760Source |
| General and Administrative ExpenseUSD | 1,229,516Source |
| Net Income (Loss) Attributable to ParentUSD | -12,162,391Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -12,162,391Source |
| Operating ExpensesUSD | 7,219,093Source |
income statement · annual statements
| Line item | FY 2026 |
|---|---|
| Total RevenueUSD | 14,822,799Source |
| Cost of Goods and Services Sold | — |
| Operating Income (Loss)USD | -4,800,840Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -12,162,391Source |
| Net Income (Loss) Attributable to ParentUSD | -12,162,391Source |
| Earnings Per Share, BasicUSD per share | -8,108.26Source |
| Earnings Per Share, DilutedUSD per share | -8,108.26Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 1,500Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 1,500Source |
| Additional Financial Items | |
| General and Administrative ExpenseUSD | 1,229,516Source |
| Gross ProfitUSD | 2,418,253Source |
| Marketing and Advertising ExpenseUSD | 80,910Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -12,162,391Source |
| Operating ExpensesUSD | 7,219,093Source |
| Other IncomeUSD | 15,832Source |
| Research and Development ExpenseUSD | 5,490,185Source |
| Selling and Marketing ExpenseUSD | 499,392Source |
Filing attachments
exascalelabs_ex99-1.htm · 8-K · 2026-09-28
Exhibit 99.1 Exascale Labs Holdings Inc. Reports 111% Revenue Growth for Full Fiscal Year 2026 and Provides Business Update Following Successful Nasdaq Listing Fiscal year 2026 revenue increased 111% to $14.8 million, compared to $7.0 million in fiscal year 2025, driven by accelerating demand for the Company’s software-defined GPU-as-a-Service platform. Successfully completed business combination with D. Boral ARC Acquisition I Corp.; commenced trading on Nasdaq under ticker symbols “XLAB…
Read attachment ↗exascalelabs_ex99-1.htm · 8-K/A · 2026-09-28
Exhibit 99.1 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Audited Consolidated Financial Statements of Exascale Labs Inc.: Report of Independent Registered Public Accounting Firm (PCAOB ID: 7000) F-2 Consolidated Balance Sheets as of June 30, 2025 and 2026 F-3 Consolidated Statements of Operations and Comprehensive Loss for the years ended June 30, 2025 and 2026 F-4 Consolidated Statements of C…
Read attachment ↗exascalelabs_ex99-2.htm · 8-K/A · 2026-09-28
Exhibit 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF EXASCALE LABS INC. The following discussion and analysis of the financial condition and results of operations of Exascale Labs Inc. (“Legacy Exascale”) for the years ended June 30, 2026 and 2025 is included as Exhibit 99.2 to Amendment No. 1 (the “Amendment”) to the Current Report on Form 8-K filed by Exascale Labs Holdings Inc. (“PubCo”) with the SEC on September 2, 2026 (the “Original Form …
Read attachment ↗exascalelabs_ex4-2.htm · 10-K · 2026-09-28
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of the date of the Annual Report on Form 10-K of which this exhibit is a part, Exascale Labs Holdings Inc. (the “Company,” “we,” “us” or “our”) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) our Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), an…
Read attachment ↗exascalelabs_ex99-1.htm · 8-K · 2026-09-02
EX-99.1 9 exascalelabs_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction Capitalized terms used and not defined in this Exhibit shall have the meanings assigned to them in the Current Report on Form 8-K to which this Exhibit is attached. As previously disclosed, On January 11, 2026, BCAR, Exascale, PubCo and Merger Sub entered into the Business Combination Agreement. The Business Combination closed on August 27, 2026. BCAR is …
Read attachment ↗exascalelabs_ex99-2.htm · 8-K · 2026-09-02
EX-99.2 10 exascalelabs_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Exascale Labs Holdings Inc. Announces Closing of Business Combination with D. Boral ARC Acquisition I Corp. and Commencement of Trading on Nasdaq under Ticker Symbol “XLAB” Exascale to begin trading tomorrow, August 28, 2026, on Nasdaq under the symbol “XLAB” ───────────────────────────────────────────────────────────────────────────────── Next-generation AI infrastructure provider with scalable platform and approxima…
Read attachment ↗